Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 69367-423

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 69367-423). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sevelamer 01)

FDA Label Image

Chemical Structure (Sevelamer 02)

FDA Label Image

Chemical Structure (Sevelamer 03)

This text provides information about the percentage of patients experiencing a 2x reduction in serum phosphorus levels when treated with Sevelamer Hydrochloride compared to an active control. The data indicates the impact of the medication on reducing serum phosphorus levels from baseline.*

FDA Label Image

Chemical Structure (Sevelamer 04)

FDA Label Image

Principal Display Panel (800 mg Tablet Bottle Label)

This text provides information about a medication called Sevelamer Carbonate in film-coated tablet form containing 800 mg of the active ingredient. The usual dosage information is not specified, and the tablets are manufactured by Bora Pharmaceutical Laboratories in Zhunan, Taiwan, for Westminster Pharmaceuticals, LLC based in Nashville, TN. The tablets come in a package of 270 tablets and the product's expiration date is August 2025. The National Drug Code (NDC) for this medication is 69367-423-27, and it is for prescription use only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.